Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer
Open Access
- 1 November 2006
- journal article
- pathobiology in-focus
- Published by Elsevier in Laboratory Investigation
- Vol. 86 (11) , 1099-1102
- https://doi.org/10.1038/labinvest.3700477
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate CancerCancer Research, 2006
- Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with RearrangementNeoplasia, 2006
- Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancerGenes, Chromosomes and Cancer, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during pubertyThe FASEB Journal, 2004
- Classification of pediatric acute lymphoblastic leukemia by gene expression profilingBlood, 2003
- Classification of Clear-Cell Sarcoma as a Subtype of Melanoma by Genomic ProfilingJournal of Clinical Oncology, 2003
- Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cellsNature Genetics, 2003
- Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysisThe Prostate, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001